CIK 0001615219 · Non-accelerated filer<br>Smaller reporting company
Decoy Therapeutics Inc.
Sign in to watch- Ticker
- DCOY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 465087339
- Phone
- 346-772-0346
- Business address
- 2450 HOLCOMBE BLVD, SUITE J-608, HOUSTON, TX, 77021
- Former names
- Salarius Pharmaceuticals, Inc., Flex Pharma, Inc.
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- DEF 14A Proxy Proxy Statement
- 8-K Event Bylaws or fiscal year change · Other events
- 8-K Event Delisting notice
- 4 Open-market sale Director sold 27 shares at $0.64 ($17)
- 8-K Event Shareholder vote results
- PRE 14A Proxy Proxy Statement (Preliminary)
- DEFA14A Proxy Proxy Materials
- 8-K Event Shareholder vote results · Regulation FD disclosure
- 4 Open-market buy Director bought 5,000 shares at $0.75 ($3,741)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Exec VP Finance, CFO bought 20,000 shares at $0.80 ($16,000)
- 8-K Event Executive or director change
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Material agreement · Acquisition or sale completed · Unregistered share sale · Shareholder rights changed · Executive or director change · Bylaws or fiscal year change · Other events
Page 3 of 38 · 744 filings